[Weaning in cardiopulmonary bypass patients with compromised cardiac function. Comparison of enoximone and dopamine]

Minerva Anestesiol. 1997 Jan-Feb;63(1-2):1-8.
[Article in Italian]

Abstract

Objective: Evaluate the effects of enoximone and dopamine in patients with impaired left ventricular function after cardiopulmonary bypass (CPB).

Design: Prospective study on a consecutive series of patients subdivided into two groups: enoximone (Group E) and dopamine (Group D).

Setting: Policlinico Umberto I, University La Sapienza of Rome.

Patients and methods: Thirty patients undergoing elective myocardial revascularization. Before weaning from CPB the patients received inotropic drugs as follows: Group E: enoximone: bolus: 1 mg/kg in 10 min, and continuous infusion of 5 mcg/kg/min; Gruppo D: dopamine: continuous infusion of 5 mcg/kg/min. Hemodynamic measurements were made using a Swan-Ganz catheter inserted before the induction of anaesthesia.

Results: Enoximone has proved to be effective in decreasing pre-load and after-load of both right and left ventricle by a positive lusitropic effect and a reduction of systolic stress, thereby increasing the cardiac index. In group D patients maintenance of cardiac output has been demonstrated to be dependent on a chronotropic effect. As a consequence in group D the increase in rate-pressure product has reached potentially dangerous values, reflecting a marked increase in myocardial oxygen consumption. On the contrary in Group E the increase in rate-pressure product has been much more limited. Finally both drugs have proven effective, since all patients have been easily weaned from CPB.

Conclusions: Enoximone is a useful and easily-handled drug to facilitate weaning from CPB of patients with preoperative impaired ventricular function.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Assisted Circulation*
  • Cardiopulmonary Bypass*
  • Cardiotonic Agents / therapeutic use*
  • Coronary Disease / physiopathology
  • Coronary Disease / surgery*
  • Dopamine / therapeutic use*
  • Enoximone / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Ventricular Function, Left

Substances

  • Cardiotonic Agents
  • Enoximone
  • Dopamine